Predictors for successful downstaging in patients with BCLC intermediate stage hepatocellular carcinoma

Authors :: M. Fiocco
Andrzej Baranski
H. W. Verspaget
Dave Sprengers
Mark C. Burgmans
A. Broekhoven
S. Osanto
S. van Meer
K.J. van Erpecum
Minneke J. Coenraad
S. Ramsoekh
B. Takkenberg
Source :: Journal of Hepatology. 66:S212-S213
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
Hepatology
business.industry
Internal medicine
Hepatocellular carcinoma
Medicine
In patient
business
medicine.disease
Intermediate stage

Full Text Access

Tools